BioScience Health Innovations Inc held $662K in cash and equivalents at the end of fiscal year 2025, and long-term debt is not reported for that period. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters BioScience Health Innovations Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BHICD Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
BHICD Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More BioScience Health Innovations Inc financials
Frequently Asked Questions
What was BioScience Health Innovations Inc's long-term debt in fiscal year 2025?
BioScience Health Innovations Inc held $662K in cash and equivalents at the end of fiscal year 2025, and long-term debt is not reported for that period.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what BioScience Health Innovations Inc (BHICD) reported on that line in every period on record.